ArticleMolecular immunology2022

Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models.

Shahram Nazarian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.